Recruiting A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis NCT07121413 Conditions Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis(IPF), Lung Diseases, +3 more Locations Sichuan Provincial People's Hospital — Chengdu, China The First Affiliated Hospital of Guangzhou Medical University — Guangzhou, China Hangzhou First People's Hospital — Hangzhou, China The First Affiliated Hospital of Nanchang University — Nanchang, China View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting CAR-DC for End-Stage IPF NCT07329959 Conditions Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis(IPF), Lung Diseases, +3 more Locations Not specified View Trial Details
Not Yet Recruiting Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF NCT06914713 Conditions Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis(IPF), Lung Diseases, +3 more Locations the First Affiliated Hospital of Henan University of Chinese Medicine — Zhengzhou, Henan, China View Trial Details
Completed Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults NCT03619616 Conditions Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis(IPF), Lung Diseases, +4 more Locations The Third Xiangya Hospital of Central South University — Changsha, Hunan, China View Trial Details
